Advertisement Encore Consumer Capital announces sale of Isopure to Glanbia - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Encore Consumer Capital announces sale of Isopure to Glanbia

Encore Consumer Capital, a private equity firm that invests exclusively in leading consumer products companies, has completed the sale of The Isopure Company, to Glanbia, the Ireland-based global performance nutrition and ingredients company, for $153m.

Robert Brown, managing director of Encore Consumer Capital, said, "Isopure’s founder Hal Katz decided to bring on a strategic and financial partner in 2007, and Encore was well positioned to help the company grow. We could not be more proud of what the team has accomplished in building the premier brand in protein-based sports nutrition."

"Encore provided strategic guidance and unwavering confidence in our team to execute our vision," said Hal Katz, Founder and now-retired CEO of Isopure. Katz added,

"Over thirty years we built a high-performance culture and special brand based on quality and authenticity. We are delighted to see those things valued by a company as highly regarded as Glanbia." Isopure will continue to be led by President Chris Hickey as part of Glanbia Performance Nutrition.

"Glanbia is the perfect partner to accelerate our expansion into new products and new markets," commented Hickey.

Sawaya Segalas & Co. LLC provided strategic and financial advisory services to Isopure. Latham and Watkins, LLP acted as legal counsel to Isopure.